Transfected Stable Cell Lines

RPMI-8226/Luciferase Stable Cell Line

  • For research use only

Cat No.

ABC-RC029Y

Product Type

Reporter Stable Cell Lines

Cell Type

B Lymphocyte

Species

Human

Host Cell

RPMI-8226

Source Organ

Peripheral Blood

Disease

Myeloma

Storage

Liquid Nitrogen

RPMI-8226/Luciferase Stable Cell Line by AcceGen for sensitive bioluminescent tracking of multiple myeloma progression and drug response in vivo.

Product Image

Description

RPMI-8226/Luciferase Stable Cell Line is a genetically engineered human multiple myeloma model developed through stable integration of luciferase into RPMI-8226 cells. This engineered cell line maintains characteristic plasma cell morphology and retains native multiple myeloma markers (CD38, CD138) while enabling sensitive, quantitative tracking of tumor progression. The constitutive luciferase expression permits real-time monitoring of tumor growth kinetics, metastatic spread, and treatment response through non-invasive bioluminescence imaging. Particularly valuable for preclinical drug development and metastasis studies, this cell line provides high sensitivity for detecting minimal residual disease in animal models. Cryopreserved at low passage (<P20) to ensure stable reporter expression and genetic integrity. The cells are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast and Bacteria.

Species

Human

Cat.No

ABC-RC029Y

Product Category

Transfected Stable Cell Lines

Size/Quantity

1 vial

Cell Type

B Lymphocyte

Growth Mode

Suspension

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Myeloma

Biosafety Level

2

Storage

Liquid Nitrogen

Product Type

Reporter Stable Cell Lines

Host Cell

RPMI-8226

Gene Info

Luciferase

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Application

  • The RPMI-8226/Luciferase Stable Cell Line is an engineered variant of the human multiple myeloma cell line RPMI-8226 with stable luciferase (Luc) expression. This bioluminescent reporter enables sensitive, quantitative tracking of tumor growth and metastasis in both in vitro assays and in vivo xenograft models using D-luciferin substrate. Particularly valuable for high-throughput drug screening and longitudinal therapy monitoring, this cell line provides non-invasive measurement of tumor burden via bioluminescence imaging (BLI). Maintain in standard RPMI-1640 medium with appropriate antibiotic selection.

Inquiring RPMI-8226/Luciferase Stable Cell Line

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button